EUVIMEDEUVIMED entdecken
Crossref

CD1530, selective RARγ agonist, facilitates Achilles tendon healing by modulating the healing environment including less chondrification in a mouse model

Dilimulati Yimiti, Kenta Uchibe, Minoru Toriyama, Yuta Hayashi, Yasunari Ikuta, Tomoyuki Nakasa, Haruhiko Akiyama, Hitomi Watanabe, Gen Kondoh, Aki Takimoto, Chisa Shukunami, Nobuo Adachi und 1 weitere

Journal of Orthopaedic Research · 2025-02 · 43 (2) · 273-284

DOI: 10.1002/jor.26006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Orthopaedic Research, online erschienen am 08.11.2024. Verfasst von Dilimulati Yimiti und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Hauptthemen laut MEDLINE: Achilles Tendon, Retinoic Acid Receptor gamma, Wound Healing. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Nakatomi Foundation, Japan Science and Technology Corporation, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heterotopic ossification (HO) in Achilles tendon often arises due to endochondral ossification during the healing process following trauma. Retinoic acid receptor γ (RARγ) plays a critical role in this phenomenon. This study aims to elucidate the therapeutic effects of CD1530, an RARγ selective agonist, along with the contributing cells, in Achilles tendon healing, utilizing a cell lineage tracing system. Local injection of CD1530 facilitated histological tendon healing by inhibiting chondrification in a mouse Achilles rupture model. Resident Scleraxis (Scx) + cells in Achilles tendon were not found to be actively involved in HO or tendon healing following injury. Instead, these processes were primarily driven by tendon stem/progenitor cells (TSPC)‐like cells. Furthermore, an in vitro assay revealed that CD1530 attenuated inflammation in injured Achilles tendon‐derived tendon fibroblasts (iATF) and inhibited the chondrogenesis of iATF. This dual effect suggests the potential of CD1530 in effectively modulating the healing environment during tendon healing. Together, the present study demonstrated that the local administration of CD1530 accelerated tendon healing by modulating the healing environment, including reducing chondrification via targeting TSPC‐like cells in a mouse Achilles tendon rupture model. These results suggest that CD1530 may have the potential to be a novel tendon therapy that offers benefits via the inhibition of chondrogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Achilles TendonRetinoic Acid Receptor gammaWound HealingAnimalsTendon InjuriesDisease Models, AnimalMice, Inbred C57BLMaleMiceOssification, HeterotopicReceptors, Retinoic AcidChondrogenesisFibroblasts

Stichwörter der Autor:innen

Achilles tendon healingchondrificationossificationretinoic acid receptor γ selective agonisttendon stem/progenitor cells

Substanzen

Retinoic Acid Receptor gammaReceptors, Retinoic Acid

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Department of Maxillofacial Anatomy and Neuroscience, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Department of Musculoskeletal Traumatology and Reconstructive Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Department of Artificial Joints and Biomaterials, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Department of Orthopaedic Surgery, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Laboratory of Integrative Biological Science, Institute for Life and Medical Sciences (LIME), Kyoto University, Kyoto, Japan.

ORCID-Profile: Shigeru Miyaki

Förderung

  • Nakatomi Foundation
  • Japan Science and Technology Corporation
  • Japan Society for the Promotion of Science

Zitieren

APA

Yimiti, D., Uchibe, K., Toriyama, M., Hayashi, Y., Ikuta, Y., Nakasa, T., Akiyama, H., Watanabe, H., Kondoh, G., Takimoto, A., Shukunami, C., Adachi, N., & Miyaki, S. (2025). CD1530, selective RARγ agonist, facilitates Achilles tendon healing by modulating the healing environment including less chondrification in a mouse model. Journal of Orthopaedic Research, 43(2), 273-284. https://doi.org/10.1002/jor.26006

Vancouver

Yimiti D, Uchibe K, Toriyama M, Hayashi Y, Ikuta Y, Nakasa T, et al. CD1530, selective RARγ agonist, facilitates Achilles tendon healing by modulating the healing environment including less chondrification in a mouse model. Journal of Orthopaedic Research. 2025;43(2):273-284. doi:10.1002/jor.26006

BibTeX
@article{Yimiti2025,
  author = {Yimiti, Dilimulati and Uchibe, Kenta and Toriyama, Minoru and Hayashi, Yuta and Ikuta, Yasunari and Nakasa, Tomoyuki and Akiyama, Haruhiko and Watanabe, Hitomi and Kondoh, Gen and Takimoto, Aki and Shukunami, Chisa and Adachi, Nobuo and Miyaki, Shigeru},
  title = {CD1530, selective RARγ agonist, facilitates Achilles tendon healing by modulating the healing environment including less chondrification in a mouse model},
  journal = {Journal of Orthopaedic Research},
  year = {2025},
  volume = {43},
  number = {2},
  pages = {273--284},
  doi = {10.1002/jor.26006}
}
Kostenlos starten →